Consultant — Rare Diseases Lead
Tel: +44 (0) 1223 913 025
As the Rare Diseases Lead at Costello Medical, Annabel leads a range of project types across our different service offerings, and has a specialist interest in orphan and ultra-orphan indications.
Annabel has experience in a wide-range of rare diseases, including paediatric conditions and genetic disorders, where she has led teams to successfully provide high-quality project support at various stages of clinical development. Annabel is passionate about the societal value of treatments for rare diseases and is dedicated to the delivery of pro bono support to a number of rare disease charities, including our long-term collaboration with the rare disease charity Findacure. Annabel plays an active role in academic discussions in this area, leading an issue panel at the 2016 European ISPOR conference focussed on off-label treatments in rare diseases. Annabel was also a panellist at DPharm Europe 2016, discussing Costello Medical’s ongoing collaborative work developing economic models focused on drug repurposing in rare diseases.
Prior to joining Costello Medical in April 2015, Annabel completed a PhD in Cell and Developmental Biology at the University of Cambridge, having previously received an upper second class BA in Natural Sciences at the same institution. During her PhD, Annabel used a combination of imaging, genetics and computer modelling to examine the role and relationship of four intracellular proteins that mediate the link between cells and the surrounding extracellular matrix. Following her PhD, Annabel volunteered with a non-governmental organisation in Cambodia, cementing her enthusiasm for the healthcare sector and charity work.